75 related articles for article (PubMed ID: 18398991)
1. New safety information for erythropoiesis-stimulating agents.
AIDS Clin Care; 2007 May; 19(5):46. PubMed ID: 18398991
[No Abstract] [Full Text] [Related]
2. Erythropoietin stimulating agents and epoetin alfa revisited: what's really relevant?
Walker RG
Clin J Am Soc Nephrol; 2008 Jul; 3(4):935-7. PubMed ID: 18579671
[No Abstract] [Full Text] [Related]
3. Revisions in the prescribing information for Epoetin alfa: implications for nephrology nurses and patients on dialysis.
Hayslip D
Nephrol Nurs J; 2008; 35(2):163-7. PubMed ID: 18472685
[TBL] [Abstract][Full Text] [Related]
4. Erythropoiesis-stimulating agents in patients with cancer: update on safety issues.
Pirker R
Expert Opin Drug Saf; 2009 Sep; 8(5):515-22. PubMed ID: 19637988
[TBL] [Abstract][Full Text] [Related]
5. The controversy surrounding hemoglobin and erythropoiesis-stimulating agents: what should we do now?
Singh AK
Am J Kidney Dis; 2008 Dec; 52(6 Suppl):S5-13. PubMed ID: 19010260
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of once-weekly intravenous epoetin alfa in maintaining hemoglobin levels in hemodialysis patients.
Locatelli F; Villa G; Messa P; Filippini A; Cannella G; De Ferrari G; Naso A; Rossi E; Formica M; Lombardi L; Rotolo U; Conte F
J Nephrol; 2008; 21(3):412-20. PubMed ID: 18587731
[TBL] [Abstract][Full Text] [Related]
7. Erythropoiesis-stimulating agents in cancer.
Arcasoy MO
J Clin Oncol; 2008 Jun; 26(18):3097-8; author reply 3098-100. PubMed ID: 18565902
[No Abstract] [Full Text] [Related]
8. FDA warns about counterfeit drug.
AIDS Patient Care STDS; 2003 May; 17(5):258. PubMed ID: 12825589
[No Abstract] [Full Text] [Related]
9. Updated clinical practice guidelines on erythropoiesis-stimulating agents.
Silver SM
Clin Adv Hematol Oncol; 2007 Dec; 5(12):945-6. PubMed ID: 18277954
[No Abstract] [Full Text] [Related]
10. FDA warns about counterfeit Epogen.
AIDS Alert; 2002 Aug; 17(8):102-3. PubMed ID: 12647693
[No Abstract] [Full Text] [Related]
11. Erythropoiesis-stimulating agents: creation and validation of a computerized prescriber order entry alert.
Ensor CR; Kockler DR; Dugger RW; Hylton-Gravatt LA
Ann Pharmacother; 2009 Jun; 43(6):1143-4. PubMed ID: 19458108
[No Abstract] [Full Text] [Related]
12. Pharmacokinetics and pharmacodynamics of six epoetin alfa dosing regimens in anemic critically ill patients without acute blood loss.
Arroliga AC; Guntupalli KK; Beaver JS; Langholff W; Marino K; Kelly K
Crit Care Med; 2009 Apr; 37(4):1299-307. PubMed ID: 19242343
[TBL] [Abstract][Full Text] [Related]
13. Counterfit drugs: check Combivir, Serostim, Epogen.
James JS
AIDS Treat News; 2002 May; (380):3-4. PubMed ID: 12085844
[No Abstract] [Full Text] [Related]
14. Reconsideration of American Society of Clinical Oncology/American Society of Hematology Erythropoiesis-stimulating Agent Guidelines.
Murray N; Klasa R
J Clin Oncol; 2008 Jun; 26(18):3096-7. PubMed ID: 18565901
[No Abstract] [Full Text] [Related]
15. [The neurohumoral regulation of erythropoiesis].
GRAF F; TAKACSI-NAGY L
Folia Haematol Int Mag Klin Morphol Blutforsch; 1963; 80():129-37. PubMed ID: 13949741
[No Abstract] [Full Text] [Related]
16. HX575, recombinant human epoetin alfa, for the treatment of chemotherapy-associated symptomatic anaemia in patients with solid tumours.
Weigang-Köhler K; Vetter A; Thyroff-Friesinger U
Onkologie; 2009 Apr; 32(4):168-74. PubMed ID: 19372711
[TBL] [Abstract][Full Text] [Related]
17. Impact of elevated C-reactive protein levels on erythropoiesis- stimulating agent (ESA) dose and responsiveness in hemodialysis patients.
Bradbury BD; Critchlow CW; Weir MR; Stewart R; Krishnan M; Hakim RH
Nephrol Dial Transplant; 2009 Mar; 24(3):919-25. PubMed ID: 18840893
[TBL] [Abstract][Full Text] [Related]
18. Tumor progression associated with erythropoiesis-stimulating agents.
Newland AM; Black CD
Ann Pharmacother; 2008 Dec; 42(12):1865-70. PubMed ID: 19017828
[TBL] [Abstract][Full Text] [Related]
19. A comparison between once-weekly and twice- or thrice-weekly subcutaneous injection of epoetin alfa: results from a randomized controlled multicentre study.
Lee YK; Kim SG; Seo JW; Oh JE; Yoon JW; Koo JR; Kim HJ; Noh JW
Nephrol Dial Transplant; 2008 Oct; 23(10):3240-6. PubMed ID: 18469158
[TBL] [Abstract][Full Text] [Related]
20. Erythropoietin in cancer-related anemia.
Fenner MH; Ganser A
Curr Opin Oncol; 2008 Nov; 20(6):685-9. PubMed ID: 18841051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
